Combined therapies for the treatment of technically unresectable liver malignancies: Bland embolization and radiofrequency thermal ablation within the same session

CardioVascular and Interventional Radiology

Volumn 35, Issue 6, 2012, Pages 1372-1379

  Bonomo, Guido ^a   Della Vigna, Paolo ^a   Monfardini, Lorenzo ^a   Orgera, Gianluigi ^a   Chiappa, Antonio ^a,b   Bianchi, Paolo Pietro ^a   Zampino, Maria Giulia ^a   Orsi, Franco ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Embolization; Liver metastases; Radiofrequency

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BLEEDING; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COIL EMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEVASCULARIZATION; FEASIBILITY STUDY; FEMALE; HUMAN; LIVER METASTASIS; MALE; OVERALL SURVIVAL; PAIN; PATIENT SAFETY; PERCUTANEOUS DRAINAGE; PLEURA EFFUSION; POSTABLATION SYNDROME; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SUBCAPSULAR HEMATOMA; SURVIVAL RATE; SURVIVAL TIME; ANGIOGRAPHY; CATHETER ABLATION; LIVER TUMOR; METASTASIS; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGRAPHY; CATHETER ABLATION; COMBINED MODALITY THERAPY; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84877751248     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-012-0341-0     Document Type: Article

References (36)

1. Olnes MJ, Erlich R (2004) A review and update on cholangiocarcinoma. Oncology 66:167-179
2. Sasson AR, Sigurdson ER (2002) Surgical treatment of liver metastases. Semin Oncol 29:107-118
3. Biasco G, Derenzini E, Grazi G et al (2006) Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties. Cancer Treat Rev 32:214-228
4. Meyerhardt JA, Mayer RY (2005) Systemic therapy for colorectal cancer. N Engl J Med 352:476-487
5. Goldberg SN, Gazelle GS (2001) Radiofrequency tissue ablation: physical principles and techniques for increasing coagulation necrosis. Hepatogastroenterology 48:359-367
6. Goldberg SN, Hahn PF, Tanabe KK et al (1998) Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 9:101-111
7. Nakai M, Sato M, Sahara S et al (2007) Radiofrequency ablation in a porcine liver model: effects of transcatheter arterial embolization with iodized oil on ablation time, maximum output, and coagulation diameter as well as angiographic characteristics. World J Gastroenterol 13:2841-2845
8. Mostafa EM, Ganguli S, Faintuch S et al (2008) Optimal strategies for combining transcatheter arterial chemoembolization and radiofrequency ablation in rabbit VX2 hepatic tumors. J Vasc Interv Radiol 19:1740-1748
9. Cheng BQ, Jia CQ, Liu CT et al (2008) Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm. JAMA 299:1669-1677
10. Takaki H, Yamakado K, Uraki J et al (2009) Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm. J Vasc Interv Radiol 20:217-224
11. Liu CH, Arellano RS, Uppot RN et al (2010) Radiofrequency ablation of hepatic tumours: effect of post-ablation margin on local tumour progression. Eur Radiol 20:877-885
12. Brown DB, Cardella JF, Sacks D et al (2006) Quality improvement guidelines for transhepatic arterial chemoembolization, embolization and chemiotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol 17:225-232
13. Goldberg SN, Grassi CJ, Cardella JF et al (2009) Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 20:s377-s390
14. Curley SA, Izzo F, Ellis LM et al (2000) Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 232:381-391
15. Solbiati L, Livraghi T, Goldberg SN et al (2001) Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer: long-term results in 111 patients. Radiology 221:159-166
16. Lin SM, Lin CJ, Lin CC et al (2005) Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 54:1151-1156
17. Primrose JN (2002) Treatment of colorectal metastases: surgery, cryotherapy, or radiofrequency ablation. Gut 50:1-5
18. O'Rourke AP, Haemmerich D, Prakash P et al (2007) Current status of liver tumor ablation devices. Expert Rev Med Devices 4:523-537
19. Flanders VL, Gervais DA (2010) Ablation of liver metastases: current status. J Vasc Interv Radiol 21:S214-S222
20. Nesbitt C, Glendinning RJ, Byrne C et al (2007) Factors that influence treatment strategies in advanced colorectal cancer. Eur J Surg Oncol 33:s88-s94
21. Llovet JM, Bruix J (2008) Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 48:S20-S37
22. Livraghi T, Meloni F, Goldberg SN et al (2000) Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 214:761-768
23. Liapi E, Geschwind JFH (2007) Transcatheter and ablative therapeutic approaches for solid malignancies. J Clin Oncol 25:978-986
24. Takaki H, Yamakado K, Uraki J et al (2009) Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinoma larger than 5 cm. J Vasc Interv Radiol 20:217-224
25. Liao GS, Yu CY, Chan DC et al (2009) Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma. Eur J Surg Oncol 34:61-66
26. Veltri A, Moretto P, Doriguzzi A et al (2006) Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol 16:661-669
27. Vogl TJ, Mack MG, Balzer JO et al (2003) Liver metastases: neoadjuvant downsizing with trans-arterial chemoembolization before laser-induced thermotherapy. Radiology 229:457-464
28. Nakai M, Sato M, Sahara S et al (2007) Radiofrequency ablation in a porcine liver model: effects on transcatheter arterial embolization with iodized oil on ablation time, maximum output, and coagulation diameter as well as angiographic characteristics. World J Gastreoenterol 13:2841-2845
29. Cady B, Jenkins R, Steele GD et al (1998) Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant outcome. Ann Surg 227:566-571
30. Poston GJ (2004) Surgical strategies for colorectal liver metastases. Surg Oncol 13:125-136
31. Ekberg H, Tranberg KG, Andersson R et al (1986) Determinants of survival in liver resection for colorectal secondaries. Br J Surg 73:727-731
32. Scheele J, Stang R, Altendorf-Hofmann A et al (1995) Resection of colorectal liver metastases. World J Surg 19:59-71
33. Kokudo N, Miki Y, Sugai S et al (2002) Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection. Arch Surg 137:833-840
34. Cheng BQ, Jia CQ, Liu CT et al (2008) Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm. A randomized controlled trial. JAMA 299:1669-1677
35. Kang SG, Yoon CJ, Jeong SH et al (2009) Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study. J Vasc Interv Radiol 20:1570-1577
36. Simmonds PC, Primrose JN, Colquitt JL et al (2006) Surgical resection of hepatic metastases from colorectal cancer: systematic review of published studies. Br J Cancer 94:982-999